PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryNov 7, 2001	Integra LifeSciences Reports Record Third Quarter Net Income on 31% Growth in Product Sales Integra LifeSciences Reports Record Third Quarter Net Income on 31 PLAINSBORO, N.J., Nov 7, 2001 (BUSINESS WIRE) -- Operating Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $5.4 Million Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:	View HTML Integra LifeSciences Reports Record Third Quarter Net Income on 31% Growth in Product Sales 22.3 KB
Toggle SummaryOct 31, 2001	Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance PLAINSBORO, N.J., Oct 31, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced that it has	View HTML Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance 10.4 KB
Toggle SummaryOct 18, 2001	Integra LifeSciences to Present at the Techvest 3rd Annual Conference on Tissue Repair, Replacement and Regeneration Integra LifeSciences to Present at the Techvest 3rd Annual Conference on Tissue Repair, Replacement and Regeneration PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 18, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it is scheduled to present at the Techvest 3rd Annual	View HTML Integra LifeSciences to Present at the Techvest 3rd Annual Conference on Tissue Repair, Replacement and Regeneration 9.8 KB
Toggle SummaryOct 17, 2001	Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents PLAINSBORO, N.J.--(BUSINESS WIRE)--Oct. 17, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that the United States District Court for the Southern	View HTML Federal Judge Enters Final Post-Judgment Orders In Favor Of Integra Lifesciences -- Merck KGaA Held To Infringe Patents 14 KB
Toggle SummaryOct 1, 2001	Integra NeuroSciences Announces New Product Launches at the Congress of Neurological Surgeons Meeting Integra NeuroSciences Announces New Product Launches at the Congress of Neurological Surgeons Meeting PLAINSBORO, N.J., Oct 1, 2001 (BUSINESS WIRE) -- Integra NeuroSciences, the neurosurgical device division of Integra LifeSciences Holdings Corporation (Nasdaq:IART), today announced that it is	View HTML Integra NeuroSciences Announces New Product Launches at the Congress of Neurological Surgeons Meeting 14.3 KB
Toggle SummarySep 24, 2001	Integra LifeSciences Announces Conference Call for October 2, 2001 to Update Financial Outlook Integra LifeSciences Announces Conference Call for October 2, 2001 to Update Financial Outlook PLAINSBORO, N.J., Sep 24, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has scheduled a conference call for Tuesday, October 2, 2001 at 8:30 AM	View HTML Integra LifeSciences Announces Conference Call for October 2, 2001 to Update Financial Outlook 10.4 KB
Toggle SummaryAug 23, 2001	Integra LifeSciences Announces Repayment of Bank Loans and Termination of Credit Facility Integra LifeSciences Announces Repayment of Bank Loans and Termination of Credit Facility PLAINSBORO, N.J., Aug 23, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has repaid in full $7.9 million of bank loans and terminated its $4.0 million	View HTML Integra LifeSciences Announces Repayment of Bank Loans and Termination of Credit Facility 9.8 KB
Toggle SummaryAug 15, 2001	Integra LifeSciences Announces Investor Forum at the Congress of Neurological Surgeons Meeting on October 2, 2001 Integra LifeSciences Announces Investor Forum at the Congress of Neurological Surgeons Meeting on October 2, 2001 PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 15, 2001--Integra LifeSciences Holdings Corporation (NASDAQ: IART) announced today that it has scheduled an Investor Forum at the Congress of	View HTML Integra LifeSciences Announces Investor Forum at the Congress of Neurological Surgeons Meeting on October 2, 2001 10.2 KB
Toggle SummaryAug 13, 2001	Integra LifeSciences Holdings Corporation Closes Public Offering of 5,060,000 Shares of Common Stock Integra LifeSciences Holdings Corporation Closes Public Offering of 5,060,000 Shares of Common Stock PLAINSBORO, N.J., Aug 13, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has closed its public offering of 5,060,000 shares of common stock	View HTML Integra LifeSciences Holdings Corporation Closes Public Offering of 5,060,000 Shares of Common Stock 10.6 KB
Toggle SummaryAug 9, 2001	Integra LifeSciences Holdings Corporation Prices Public Offering of 5,060,000 Shares of Common Stock; Integra LifeSciences Holdings Corporation Prices Public Offering of 5,060,000 Shares of Common Stock; PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 9, 2001--Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced today that it has priced a public offering of 5,060,000 shares of common stock at	View HTML Integra LifeSciences Holdings Corporation Prices Public Offering of 5,060,000 Shares of Common Stock; 10.2 KB
Toggle SummaryAug 2, 2001	Integra LifeSciences Reports Record Second Quarter Net Income on 35% Growth in Product Sales Integra LifeSciences Reports Record Second Quarter Net Income on 35 PLAINSBORO, N.J.--(BUSINESS WIRE)--Aug. 2, 2001-- Earnings Before Interest, Taxes, Depreciation and Amortization Totaled $4.7 Million Led by strong growth in product sales, Integra LifeSciences Holdings Corporation (Nasdaq:IART)	View HTML Integra LifeSciences Reports Record Second Quarter Net Income on 35% Growth in Product Sales 18 KB
Toggle SummaryJul 23, 2001	Integra LifeSciences Schedules Conference Call for Thursday, August 2 to Discuss Second Quarter 2001 Results and Financial Outlook Integra LifeSciences Schedules Conference Call for Thursday, August 2 to Discuss Second Quarter 2001 Results and Financial Outlook PLAINSBORO, N.J., Jul 23, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced that it has rescheduled its conference call to	View HTML Integra LifeSciences Schedules Conference Call for Thursday, August 2 to Discuss Second Quarter 2001 Results and Financial Outlook 10.4 KB
Toggle SummaryJul 20, 2001	Integra LifeSciences Holdings Corporation Files Amendment to Registration Statement for Public Offering of Common Stock Integra LifeSciences Holdings Corporation Files Amendment to Registration Statement for Public Offering of Common Stock PLAINSBORO, N.J.--(BUSINESS WIRE)--July 20, 2001--Integra LifeSciences Holdings Corporation (NASDAQ: IART) today announced that it had filed an amendment to its registration	View HTML Integra LifeSciences Holdings Corporation Files Amendment to Registration Statement for Public Offering of Common Stock 11.7 KB
Toggle SummaryJul 5, 2001	Integra LifeSciences Announces FDA Clearance for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves Integra LifeSciences Announces FDA Clearance for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves PLAINSBORO, N.J., Jul 5, 2001 (BUSINESS WIRE) -- Product Launch to Begin in Fourth Quarter Integra LifeSciences Holdings Corporation (Nasdaq: IART) today announced that it has received	View HTML Integra LifeSciences Announces FDA Clearance for the NeuraGen Nerve Guide for Repair of Severed Peripheral Nerves 13.3 KB
Toggle SummaryJun 27, 2001	Integra LifeSciences Announces Completion of Grant in Advanced Biomaterials Program; Device Master File Submitted to FDA Integra LifeSciences Announces Completion of Grant in Advanced Biomaterials Program; Device Master File Submitted to FDA PLAINSBORO, N.J., Jun 27, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the successful completion of a second period of funding	View HTML Integra LifeSciences Announces Completion of Grant in Advanced Biomaterials Program; Device Master File Submitted to FDA 13 KB